Skip to main content
. 2023 Jul 25;13:11327. doi: 10.1038/s41598-023-36990-9

Figure 3.

Figure 3

Case-outcome rates of solid and haematological cancer subtypes by age group and sex (female or male) following a COVID-19 infection in 2022. Case-outcome rates for COVID-19 hospital assessment, inpatient hospitalisation, intensive care admission and mortality are shown for each cancer subtype and are colour coded according to the scales below each heatmap. Grey boxes denote < 10 SARS-CoV-2 tests within a subgroup. White boxes denote < 10 SARS-CoV-2 tests within sex-specific cancer subtypes (female gynaecological, male urological, prostate cancers). Corresponding ICD-10 codes for specific primary tumour subtypes are listed in brackets.